Super Bowl ad for copycat weight loss drugs stokes pharma power debate
Controversy surrounded Him & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting event.
10 February 2025
10 February 2025
Controversy surrounded Him & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting event.
Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.
With growing uncertainty in the trade environment, investors may delay new investments until policies become clearer.
Tim Andrews underwent the procedure with the pig kidney as part of a three-person compassionate use study.
Sanofi has agreed to purchase its own shares as part of a $5.1bn share buyback initiative in 2025.
Development of the therapy was a collaborative effort between AbbVie and Pfizer.
The funds will cover operating expenses and capital expenditure needs up to 2027.
Desmopressin is approved in various forms, but these do not meet the paediatric need for precise, titratable and small doses.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.